The Sindh Health Department had allowed three medical clinics in the area two in Karachi and one in Hyderabad to start plasma therapy trials to treat patients who are affected by novel coronaviruses and exhibit moderate to severe signs.
Plasma is taken from the blood of patients who have just recovered from the disease; For this situation, COVID-19. It is rich in antibodies and can enable individual patients to have a rapid recurrence on the off chance that it is regulated appropriately and under the right conditions.
Medical Superintendent in Civil Hospital, Dr. Shahid Junejo said that the patient who was treated has demonstrated improvement.
He stated 'The decision for the mark was taken after a conversation with the Chancellor of the Medical and Health Sciences.'
'The patient's heart rate and oxygen release after therapy are normal,' Junejo said.
The three health offices that the provincial government has allowed to start the clinical trial are Drs. Ruth KM Pfau Civil Hospital Karachi (CHK), National Institute of Blood Diseases (NIBD) and Liaquat University Hospital, Hyderabad.
NIBD Head Professor Dr. Tahir Shamsi said, "After Punjab, Balochistan and Khyber Pakhtunkhwa [KP], Sindh Health Department has allowed clinical trials of blood plasma for the treatment of COVID-19 patients in three similar medical clinics. " Talked to a media person.
"We are currently going to select 350 COVID-19 patients under treatment at nine health facilities in the nation and begin clinical trials of blood plasma on them," said the leading hematologist.
Dr. Shamsi said that the Drug Regulatory Authority of Pakistan had allowed clinical experts to start clinical trials of plasma in the nation.
'We say that COVID-19 patients are prevented from going on life support in various clinics. We acknowledge that plasma taken from solid COVID-19 patients, enriched with coronavirus antibodies, can reduce the viral burden in the collection of contaminated patients and help them recover quickly.'
Dr. Shamsi said the method is used when there is an excessive risk of contamination and time loss in the body to create its own inducible response or to reduce the progression or manifestations of immunosuppressive diseases.
'A group of health experts including hematologists, infectious diseases specialists, intensivists (or ICU masters), and an agent of the Sindh Blood Transfusion Authority will oversee clinical trials at three emergency clinics.'
He said that patients experiencing treatment mainly at CHK in Karachi and Liaquat University Hospital in Hyderabad would be given plasma with the hope of being recruited from COVID-19.
'We acknowledge that dynamic patients with recurrent plasma transfusion of sound COVID-19 patients will reduce the viral burden in patients' collections to an extent where they will not require ventilator support and they may recover from the disease.'
He said these tests would be directed at the Hayatabad Medical Complex in Peshawar, Sheikh Zayed Hospital in Quetta, Pakistan Institute of Medical Sciences in Islamabad, Benazir Bhutto Shaheed Hospital in Rawalpindi, and Pakistan Kidney and Liver Institute in Lahore and a postgraduate medical postgraduate. Institute.
Answering a question, Drs. Shamsi said that patients with sound COVID-19 who have tested negative twice can give their blood for plasma extraction after fourteen days of recovery, with a gift that they treat two such patients.
0 Comments